ABSTRACT-
Benign prostatic hypertrophy (BPH) is a progressive en largement of the prostate, occurring in men with increas ing frequency with advancing age. Symptoms such as the bladder outlet obstruction observed in these patients result from constriction of the urethra by the enlarged prostate which surrounds it (1). This enlargement is regu lated by androgen (2), but this mechanism remains un clear in BPH. The prostate is innervated by branches of both the sympathomimetic and parasympathomimetic autonomic nervous systems (3, 4) ; the response of these nerves to stimulation is mediated through adrenoceptors and cholinoceptors, which have been found in both prostatic adenoma and capsular tissues (5 7). Studies have shown that a-adrenoceptor and cholinoceptor stimu lation mediates contraction of both human (8) and rabbit prostate, while (3-adrenoceptor mediate the relaxation of rabbit prostate (9) . Muscarinic cholinoceptor stimulation increases basal prostatic secretion in dogs (10) . Further more, muscarinic agonist-induced secretory processes are down-regulated by castration and restored by the adminis tration of testosterone (7, 11) . The presence of at least three subtypes of muscarinic cholinoceptors in mammalian tissues is now well estab lished (12, 13). Moreover, molecular cloning of these receptors has demonstrated the presence of five related but distinct gene products (ml, m2, m3, m4 and m5) (14-18). We have previously shown in binding and con traction studies that adrenoceptor subtypes in human (8) and rabbit prostate (9) are mainly of the a,-type. Never theless, cholinergic regulation of the prostate remains un clear. Little information is available about the muscarinic cholinoceptor subtypes in this gland. In the present study, we investigated muscarinic cholinoceptor subtypes in the rat prostate, and the effect of aging on these receptors.
MATERIALS AND METHODS

Tissue preparation
Male Sprague-Dawley rats (200-300g, SLC, Shizu oka) were anesthetized with diethylether and the whole brain, salivary gland, heart and prostate were removed. Tissues were finely minced with scissors and homogenized in 10 vol. of ice-cold homogenization buffer (0.25 M su crose containing 50 mM tris-HC1 pH 7.5) with a polytron (Kinematica, Lucerne, Switzerland). The homogenate was centrifuged at 600 x g for 15 min at 41C. The super natant was filtered through a single layer of nylon mesh and recentrifuged at 40,000 x g for 20 min at 41C. The resulting pellets were washed twice with ice-cold incuba tion buffer (50 mM tris-HC1 pH 7.5 containing 10 mM MgC12). The final pellet was resuspended with 3 -10 vol. of ice-cold incubation buffer and stored at 80V until use.
Binding assay
Muscarinic cholinoceptor density was determined in saturation experiments by incubating aliquots of mem brane preparation (200 pg protein) with increasing concen trations of [3H]-methyl-quinuclidinyl benzilate (QNB) (0.03 1.4 nM) in a final volume of 0.5 ml for 60 min at 251C. In the competition experiments, a single concentra tion (0.1 nM) and 5 to 7 concentrations of antagonists were used. Incubation was terminated by rapid filtration through Whatman GF/C filters using a Brandel cell harvester. The filter was then rinsed 3 times with 3-ml aliquots of ice-cold incubation buffer. Radioactivity retained on the filter was counted by a liquid scintillation counter (2000CA, Packard, Meriden, CT, U.S.A.). Non specific binding was determined in the presence of 10 pM atropine; it was found to be less than 10°70 of the total binding at 0.1 nM [3H]-methyl-QNB under all conditions.
(3-Adrenoceptor binding density was determined in satu ration experiments by incubating aliquots (200 pg pro tein) of membrane prepared from rat prostate with in creasing concentrations of [3H]-dihydroalprenolol (DHA) (0.03 -1.4 nM) for 10 min at 301C. Nonspecific binding was determined in the presence of 10 pM isoproterenol. Other details were the same as those for the muscarinic binding study. The protein content of each membrane sus pension was measured by the Bradford method (19), with bovine serum albumin as the standard.
Aging study
[3H]-Methyl-QNB binding was examined in prostates obtained from male Sprague-Dawley rats aged 6 to 8 weeks (young rats) and 52 to 60 weeks (old rats) (520-690 g). The tissue was prepared and assayed as above. Six separate assays were performed in duplicate for each age group.
Statistical analyses
The data were analyzed as previously reported (20). Results were expressed as the mean ±S.E.M. or the mean with 95% confidence limits. Statistical significance was as sessed by the non-paired Student's t-test (P<0.01).
Drugs
The 
RESULTS
Radioligand binding studies were carried out on rat prostate membrane. (Fig. 1b) . Compared with other novel muscarinic cholinoceptor subtypes (MI, brain; M2, heart; M3, salivary gland), the KD values for the rat prostate were closer to those for the salivary gland than to those for the brain and heart (Table 1) . Six mus carinic cholinoceptor antagonists inhibited the [3H] methyl-QNB binding of rat prostate membrane and tis sues. The ranking order of inhibitory activity was: atro pine > 4-DAMP > p-F-HHSiD > pirenzepine > methoctra mine>AF-DX 116 (Fig. 2) . K; values for these com pounds were compared in other membranes; a good correlation (r=0.99) was obtained between the prostate and salivary gland (Fig. 3) . The M3-selective antagonist p-F-HHSiD gave the expected affinity profile-prostate (7.54) > salivary gland (7.49) > brain (7.47) > heart (6.56), again showing similar pK, values between the prostate and salivary gland (Table 2) . Furthermore, 4-DAMP (M3 selective antagonist) showed a similar affinity profile (Table 2) .
In old rats, the Bmax values for muscarinic cholinocep tor in the prostate were less than those for young rats (P<0.01) without a significant change in KD (Table 3 ). In ~-adrenoceptors, however, neither Bmax nor KD values showed any change (Table 3) . 
DISCUSSION
The major aim of the present study was to characterize the binding of [3H]-methyl-QNB to muscarinic cholino ceptors present in the rat prostate. As in other rat tissues,
[3H]-methyl-QNB binding to prostate membranes appears to involve a single population of binding sites. The KD value and maximal density of binding sites were 0.24 ±0.04 nM and 219±65 fmol/mg protein, respectively.
[3H]-Methyl-QNB affinity for these binding sites was similar to values found in the rat salivary gland (0.32-L 0.02 nM). Atropine, pirenzepine (21), AF-DX 116 (22) and methoctramine (23), and p-F-HHSiD (24) and 4-DAMP (25) , respectively, were used as non-selective, M,-selective, M2-selective and M3-selective muscarinic antagonists in competition experiments against [3H]-methyl-QNB bind ing. All these muscarinic antagonists inhibit the binding of [3H]-methyl-QNB to the binding sites in rat tissue membranes. Three different pharmacologically identifi able receptors have been proposed: M, (neuronal tissue), M2 (heart tissue) and M3 (exocrine glands), with the clas sification based on the binding characteristics of three selective ligands, pirenzepine (M,), AF-DX 116 (M2) and p-F-HHSiD (M3). We thus used brain (M,-rich mem brane), heart (M2-rich membrane) and salivary gland (M3 rich membrane) (25) in our study. Recently, five muscarin ic cholinoceptors have been cloned (m I m5), but the expression of m4 and m5 muscarinic cholinoceptors remained unclear. Hill coefficients of 5 antagonists (ex cept atropine) in heart membrane were smaller than 1. This reason might be explained by the existence of another subtype of muscarinic cholinoceptor. The rank ing order of these ligands for the M, receptor subtype was atropine = 4-DAMP>p-F-HHSiD > pirenzepine>AF-DX 116. Ranking for the M2 receptor was atropine>4 DAMP>AF-DX 116>p-F-HHSiD»pirenzepine, while that for the M3 receptor was atropine >_ 4-DAMP>p-F HHSiD>pirenzepine>AF-DX 116 (26) . The displace ment ranking order of these antagonists against [3H] methyl-QNB in rat prostate membrane (atropine > 4 DAMP > p-F-HHSiD > pirenzepine > methoctramine > AF-DX 116) was similar to that described above for the M3-muscarinic cholinoceptor subtype and for the salivary gland in this study. This order agrees with that (27) for the inhibition of the maximum acetylcholine-induced contraction of guinea pig ileum smooth muscle strips (pA2 values). Furthermore, both M3-selective antagonists, 4-DAMP and p-F-HHSiD, gave the expected affinity profile: prostate >_ salivary gland >_ brain > heart. We could not, however, clearly discriminate between M, (brain) and M3 (salivary gland) cholinoceptor because of the weak selectivity (M3/M,) of these compounds (13, 25) , and the heterogeneity of muscarinic receptors in these tis sues. Another study used ml and m3 receptors expressed by CHO-Kl cells (28) to show that pirenzepine (M,-selec tive antagonist) was 10-fold more selective for M, recep tors than M3 receptors. We saw a similar tendency in M,/M3 selectivity among these compounds (brain: pKi = 7 .72, salivary gland: 7.28, prostate: 7.43) ( Table 2 ). Fur thermore, the M2-selective (M2 > M, > M3) antagonist methoctramine showed the same rank order in this study: heart (pKi = 8.09) > brain (6.84) > salivary gland (6.22) =prostate (6 .42). Muscarinic cholinoceptors in the rat prostate may therefore be mainly M3-muscarinic cholino ceptors.
The number of autonomic receptors in prostate homog enate from aged rats was measured to study the effect of aging on autonomic receptors in this gland. (3-Adreno ceptors and muscarinic cholinoceptors were counted using
[3H]-DHA and [3H]-methyl-QNB, respectively. Results showed an apparent reduction in the number of musca rinic cholinoceptors with advancing age. Surprisingly, there have been only a few reports that age affects mus carinic cholinergic receptors in the rat prostate. Three reports (29) (30) (31) have examined muscarinic receptors in the aging rat urinary bladder. Two showed an increase (29, 30) in the density of receptors, while the other showed no change (31) . However, these discrepancies might be explained by possible differences in the nature of the tissue samples and/or rat strain. No consensus view on this question was reached. However, in other tissues (rat hippocampus (32), cow trachea (33), some reports in dicated that there was a reduction of muscarinic cholino ceptors with advancing age.
Acetylcholine causes a significant contractile response in human prostatic capsule; this response is inhibited by atropine (34) . Autoradiographic studies have localized the muscarinic cholinoceptors to the glandular epithelium (35) . The possible functional relevance of these muscarin ic receptors is evidenced by studies in which pilocarpine was shown to significantly enhance the basal output of prostatic secretions in the dog (10) . This pilocarpine induced increase in prostatic secretion has not been ob served in castrated dogs (11). The present study showed a similar down-regulation of muscarinic receptors in aged rat prostate.
In summary, our data showed a single muscarinic cholinoceptor subpopulation in the rat prostate which is similar to the M3 subtype. Furthermore, aged rats showed an apparent reduction in the number of muscarinic recep tors.
